New agent inhibits HCV replication in mouse models: No resistance seen
Thursday, May 30, 2013 - 12:00
in Health & Medicine
Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now scientists have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen.